Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) generates frequent news as a technology, engineering and science company serving defense, intelligence, civil, health and commercial markets. Company announcements highlight digital and mission innovations for government and commercial customers, reflecting its role in national security, aviation security, energy programs and civil space integration.
Investors and observers following LDOS news will see regular earnings releases and financial updates, including quarterly results, forward guidance and details on new business awards and backlog. Leidos also issues press releases on capital allocation decisions such as quarterly cash dividends, providing context on how it returns capital to shareholders alongside investments in growth areas.
Another major category of Leidos news involves contract wins and program milestones. Recent communications have described awards in classified mission support, AI-enabled mission software, undersea warfare support, air traffic management modernization and managed health services. Updates on long-term programs, such as administration of the Hawai'i Energy efficiency initiative or support for NASA human space exploration, illustrate the company’s ongoing role in multi-year government and infrastructure projects.
Leidos also reports on technology developments and partnerships. Examples include collaborations to enhance customs checkpoint inspections through AI-enabled trade analysis, integration of baggage screening technologies, certification of explosive trace detection systems to meet evolving aviation security standards, and the Imperium AI platform for information operations developed with VML. Space-related news, such as its selection to lead assembly, integration and testing for the Starlab commercial space station, further underscores its presence in civil space.
This LDOS news page on Stock Titan aggregates such updates in one place, making it easier to track financial results, contract activity, technology announcements and strategic initiatives over time.
Leidos (NYSE:LDOS) has secured a task order from the U.S. Army Contracting Command valued at approximately $210 million for providing Intelligence, Electronic Warfare and Sensors (IEW&S) system and software support. The contract includes a one-year base period with four additional one-year options. The work will primarily occur at Aberdeen Proving Ground, Md. Under this contract, Leidos will enhance the reliability and interoperability of the Army's systems through its agile software development process and portfolio management dashboard.
Leidos (NYSE: LDOS) has scheduled a conference call for August 4, 2020, at 8 a.m. (ET) to discuss its second-quarter financial results for the period ending July 3, 2020. The earnings press release will precede the call on the same day. Investors can listen via the internet or telephone, and a replay will be available from 11:30 a.m. (ET) on August 4 through 11:59 p.m. (ET) on August 11, 2020. Leidos reported $11.09 billion in annual revenues for fiscal year ending January 3, 2020.
Leidos (NYSE:LDOS) has secured a prime contract with Edinburgh Airport Limited to enhance its security tray systems by implementing antimicrobial technology. This technology reduces bacteria like E. coli and MRSA by 99.99%, addressing health concerns amid the ongoing pandemic. Leidos has collaborated with Edinburgh Airport since 2012 and aims to support improved health safety for travelers. The company reported revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, and has a strong portfolio of security detection solutions deployed in over 120 countries.
Leidos (NYSE:LDOS) has secured a $79 million contract from the Department of Veterans Affairs to design and implement a regional consolidated mail outpatient pharmacy system (CMOP). The contract includes a two-year performance period with 20 additional three-month options. Leidos aims to replace the existing facility in Leavenworth, Kansas, establishing a highly automated pharmacy capable of processing over 80,000 prescriptions daily. This initiative supports the VA's modernization efforts and enhances service to U.S. military veterans.
Leidos (NYSE: LDOS) and the Baltimore Ravens are distributing nearly 70,000 drug disposal packets across Baltimore as part of the "Tackling Opioid Addiction" campaign. This initiative aims to combat the opioid epidemic, which has escalated during the COVID-19 pandemic, with over 90% of drug-related deaths in Baltimore being opioid-related. The packets will allow residents to safely dispose of leftover prescriptions at home. Leidos has maintained a commitment to addressing opioid addiction since 2017, implementing several community-driven initiatives.